CS logo
small CS logo
Southern Maine Health Care

Biddeford, Maine, United States
Hospital in Biddeford, Maine
1 Medical Center Dr, Biddeford, ME 04005

About Southern Maine Health Care


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
1
Boehringer Ingelheim
1
Brigham and Women's Hospital
1
Ipsen
1
Kowa Research Institute, Inc.
1
Pfizer
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 7

Clinical Trials at Southern Maine Health Care


During the past decade, Southern Maine Health Care conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111220000Started TrialsCompleted Trails2017201820190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
GLORIA-AF Registry Program - Second and Third Phases
2011-11-07
2020-01-10
Completed
37,235
Cardiovascular Inflammation Reduction Trial
2013-04-01
2019-10-30
Completed
4,786
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
2018-04-25
2023-04-28
Active, not recruiting
461
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Southern Maine Health Care" #1 sponsor was "Amgen" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Ipsen" with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Maine Health Care" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 1Amgen: 1Boehringer Ingelheim: 1Boehringer Ingelheim: 1Brigham and Women'sHospital: 1Brigham and Women'sHospital: 1Ipsen: 1Ipsen: 1Kowa Research Institute, Inc.: 1Kowa Research Institute, Inc.: 1Pfizer: 1Pfizer: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsBrigham and Women'sHospital: 1Brigham and Women'sHospital: 1National Heart, Lung,and Blood Institute(NHLBI): 1National Heart, Lung,and Blood Institute(NHLBI): 1The Cleveland Clinic: 1The Cleveland Clinic: 1

Clinical Trials Conditions at Southern Maine Health Care


According to Clinical.Site data, the most researched conditions in "Southern Maine Health Care" are "Arthritis, Rheumatoid" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Southern Maine Health Care" in a lesser frequency.

Clinical Trials Intervention Types at Southern Maine Health Care


Most popular intervention types in "Southern Maine Health Care" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Evolocumab" (1 trials), "Ibuprofen" (1 trials) and "Irinotecan liposome injection" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Southern Maine Health Care


The vast majority of trials in "Southern Maine Health Care" are 7 trials for "All" genders.

Clinical Trials Status at Southern Maine Health Care


Currently, there are NaN active trials in "Southern Maine Health Care". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Southern Maine Health Care, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Southern Maine Health Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Active, not recruiting: 2Active, not recruiting: 2Terminated: 1Terminated: 1